You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Renal Cell Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Moesin Expression in Clear Cell Renal Cell Carcinoma

Completed
  • Renal Cell Carcinoma
  • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
  • (no location specified)
Sep 20, 2023

Delving Into Participation Trends in Renal Cell Carcinoma

Not yet recruiting
  • Renal Cell Carcinoma
    • San Francisco, California
      Power Life Sciences
    Oct 16, 2023

    ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

    Not yet recruiting
    • ccRCC
    • +20 more
    • (no location specified)
    Jul 6, 2023

    Renal Cell Carcinoma Trial (Sunitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 11, 2023

    Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Recruiting
    • Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jun 5, 2023

    Renal Cell Carcinoma Trial (HS-10516)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 24, 2023

    Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

    Recruiting
    • Advanced Renal Cell Carcinoma
    • ST-1898 tablets
    • Beijing, Beijing, China
      Peking University Cancer Hospital & Institute
    Nov 6, 2023

    Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Pembrolizumab injection
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Aug 20, 2023

    Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 28, 2023

    Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

    Not yet recruiting
    • Papillary Renal Cell Carcinoma
    • (no location specified)
    Nov 24, 2023

    Renal Cell Carcinoma, First-line Treatment, Non Clear Cell Renal Cell Carcinoma Trial in Chengdu (AK104, Axitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • +3 more
    • Chengdu, Sichuan, China
      West China Hospital
    Apr 10, 2023

    Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 18, 2023

    Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Metastatic Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 18, 2023

    Renal Cell Carcinoma Trial (Cytoreductive Nephrectomy)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Cytoreductive Nephrectomy
    • (no location specified)
    Jul 3, 2023

    Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

    Available
    • Clear Cell Renal Cell Carcinoma
    • 89Zr-DFO-girentuximab
    • Los Angeles, California
      UCLA
    Oct 12, 2023

    Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

    Recruiting
    • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
    • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
    • Shanghai, Shanghai, China
      Shanghai Renji Hospital
    Sep 12, 2023

    Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

    Not yet recruiting
    • Advanced Clear Cell Renal Carcinoma (Ccrcc)
    • Papillary Renal Cell Carcinoma (Prcc)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

    Not yet recruiting
    • Renal Cell Carcinoma
    • +2 more
    • Implantable Microdevice (IMD)
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 17, 2023

    Renal Cell Carcinoma Trial in Guangzhou (Pucotenlimab Combined With Lenvatinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Pucotenlimab Combined With Lenvatinib
    • Guangzhou, Other (Non U.s.), China
      Sun Yat-sen University Cancer Center
    Nov 10, 2023

    Renal Cell Carcinoma Trial in Houston (Tivozanib, Nivolumab)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 19, 2023

    Oligometastatic Renal Cell Carcinoma Trial in Houston (Pembrolizumab, Radiation therapy)

    Not yet recruiting
    • Oligometastatic Renal Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 21, 2023

    Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)

    Not yet recruiting
    • Renal Cancer
    • +3 more
    • Aurora, Colorado
      University of Colorado Cancer Center
    Jul 24, 2023

    Renal Cell Carcinoma Trial in Tabriz (Sodium Pentaborate)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Sodium Pentaborate
    • Tabriz, East Azarbayejan, Iran, Islamic Republic of
      Imam Reza hospital and Clinic of Salamat
    Mar 23, 2023

    Learn About First and Later Lines of Medicines in Treating

    Completed
    • Metastatic Renal Cell Carcinoma
      • New York, New York
        Pfizer Headquarters
      May 12, 2023

      First-line Treatment of Non-clear Renal Cell Carcinoma Trial (Fruquintinib combined with Serplulimab)

      Not yet recruiting
      • First-line Treatment of Non-clear Renal Cell Carcinoma
      • Fruquintinib combined with Serplulimab
      • (no location specified)
      Apr 16, 2023